𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P.1.031 Use of sibutramine, an inhibitor of thereuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: A placebo-controlled study

✍ Scribed by A. Casella; W. Milano; C. Petrella; A. Capasso


Book ID
118591242
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
204 KB
Volume
15
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


High-dose escitalopram in the treatment
✍ Anna I. Guerdjikova; Susan L. McElroy; Renu Kotwal; Jeffrey A. Welge; Erik Nelso πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 142 KB πŸ‘ 1 views

## Abstract ## Objective The purpose of this study was to evaluate the efficacy and safety of high‐dose escitalopram in the treatment of binge‐eating disorder (BED) associated with obesity. ## Method Forty‐four outpatients with BED by DSM‐IV criteria and obesity were randomized to receive either

Celecoxib as an adjunct in the treatment
✍ Fabiano G. Nery; Emel S. Monkul; John P. Hatch; Manoela Fonseca; Giovana B. Zunt πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 117 KB

## Abstract ## Objective To investigate whether the cox‐2 inhibitor celecoxib has antidepressant effects in bipolar disorder (BD) patients during depressive or mixed phases. ## Methods We studied 28 DSM‐IV BD patients who were experiencing a depressive or mixed episode and were on a stable dose